Wockhardt Limited (NSE:WOCKPHARMA)
India · Delayed Price · Currency is INR 1,815.00
-16.30 (-0.89%)
Jul 10, 2026, 3:30 PM IST
Wockhardt Market Cap
Wockhardt has a market cap or net worth of 294.22 billion as of July 10, 2026. Its market cap has increased by 7.32% in one year.
Market Cap
294.22B
Enterprise Value
312.83B
Revenue
33.73B
Ranking
n/a
PE Ratio
138.22
Stock Price
1,815.00
Market Cap Chart
Since February 21, 2001, Wockhardt's market cap has increased from 17.40B to 294.22B, an increase of 1,590.58%. That is a compound annual growth rate of 11.78%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 10, 2026 | 294.22B | 25.20% |
| Dec 31, 2025 | 235.00B | 2.08% |
| Dec 31, 2024 | 230.20B | 276.45% |
| Dec 29, 2023 | 61.15B | 90.30% |
| Dec 30, 2022 | 32.13B | -29.77% |
| Dec 31, 2021 | 45.75B | -24.44% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Glenmark Pharmaceuticals | 644.24B |
| Ipca Laboratories | 453.60B |
| Ajanta Pharma | 418.20B |
| Gland Pharma | 408.50B |
| Emcure Pharmaceuticals | 343.99B |
| Piramal Pharma | 235.12B |
| Eris Lifesciences | 198.32B |
| NATCO Pharma | 176.26B |